Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Stem Cell Research

Free Subscription Articles published in Transfusion Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

July 2019
1. BHOWMICK T, Rasool A, Desai A, Weinstein MP, et al
   Erythema migrans spares rash of engraftment syndrome.
   Transfusion. 2019;59:2193-2194.
   PubMed     Text format    
   
   
   June 2019
2. WARNER MA, Jambhekar NS, Saadeh S, Jacob EK, et al
   Implementation of a patient blood management program in hematopoietic stem cell transplantation.
   Transfusion. 2019 Jun 20. doi: 10.1111/trf.15414.
   PubMed     Text format     Abstract available
   
   
   May 2019
3. CID J, Carbasse G, Suarez-Lledo M, Moreno DF, et al
   Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
   Transfusion. 2019 May 28. doi: 10.1111/trf.15384.
   PubMed     Text format     Abstract available
   
   
   
4. AKEL S, Murray C, Ferguson W, Babic A, et al
   Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit.
   Transfusion. 2019 May 8. doi: 10.1111/trf.15337.
   PubMed     Text format     Abstract available
   
   
   
5. LAMARCHE MC, Hammond DE, Hopman WM, Sirosky-Yanyk A, et al
   Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
   Transfusion. 2019 May 6. doi: 10.1111/trf.15335.
   PubMed     Text format     Abstract available
   
   
   April 2019
6. GASTECKI K, Shanley R, Welbig J, Cohn C, et al
   Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation.
   Transfusion. 2019 Apr 8. doi: 10.1111/trf.15285.
   PubMed     Text format     Abstract available
   
   
   March 2019
7. KANG J, Hong JY, Yoon DH, Kim JE, et al
   Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
   Transfusion. 2019 Mar 29. doi: 10.1111/trf.15265.
   PubMed     Text format     Abstract available
   
   
   February 2019
8. JONES RE, Foster DS, Hu MS, Longaker MT, et al
   Wound healing and fibrosis: current stem cell therapies.
   Transfusion. 2019;59.
   PubMed     Text format     Abstract available
   
   
   
9. FIERRO FA, Magner N, Beegle J, Dahlenburg H, et al
   Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions.
   Transfusion. 2019;59.
   PubMed     Text format     Abstract available
   
   
   
10. HUPPERT LA, Liu KD, Matthay MA
    Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.
    Transfusion. 2019;59.
    PubMed     Text format    
    
    
    
11. GODBEY EA, Dormesy S, Gowda L, Nandi V, et al
    A dual strategy to optimize hematopoietic progenitor cell collections: validation of a simple prediction algorithm and use of collect flow rates guided by mononuclear cell count.
    Transfusion. 2019;59:659-670.
    PubMed     Text format     Abstract available
    
    
    January 2019
12. DOBERSCHUETZ N, Soerensen J, Bonig H, Willasch A, et al
    Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.
    Transfusion. 2019 Jan 4. doi: 10.1111/trf.15113.
    PubMed     Text format     Abstract available
    
    
    
13. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2019;59:12-14.
    PubMed     Text format    
    
    
    December 2018
14. ONO Y, Yoshioka S, Inoue K, Yoshida M, et al
    Stochastic model based on preharvest peripheral CD34-positive cell count and collection efficiency predicting processed blood volume in peripheral hematopoietic stem cell apheresis.
    Transfusion. 2018 Dec 28. doi: 10.1111/trf.15096.
    PubMed     Text format     Abstract available
    
    
    
15. ROHNER N, Passweg JR, Tsakiris DA, Halter JP, et al
    The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
    Transfusion. 2018 Dec 17. doi: 10.1111/trf.15107.
    PubMed     Text format     Abstract available
    
    
    
16. DE GREEF GE, Braakman E, van der Holt B, Janssen JJWM, et al
    The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
    Transfusion. 2018 Dec 11. doi: 10.1111/trf.15037.
    PubMed     Text format     Abstract available
    
    
    
17. GALEL D, Crisostomo C, Ortega J, Peters K, et al
    Nucleated red blood cells as a novel indicator of CD34(+) cell content in umbilical cord blood.
    Transfusion. 2018 Dec 7. doi: 10.1111/trf.15080.
    PubMed     Text format     Abstract available
    
    
    
18. MUNIZ ALERS SM, Page K, Simmons R, Waters-Pick B, et al
    Automated thawing increases recovery of colony-forming units from banked cord blood unit grafts.
    Transfusion. 2018;58:2911-2917.
    PubMed     Text format     Abstract available
    
    
    November 2018
19. QUEK J, Lee JJ, Lim FL, Diong C, et al
    Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Transfusion. 2018 Nov 22. doi: 10.1111/trf.15053.
    PubMed     Text format     Abstract available
    
    
    
20. PARTANEN A, Valtola J, Ropponen A, Kuitunen H, et al
    Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34(+) cells in non-Hodgkin lymphoma patients.
    Transfusion. 2018 Nov 19. doi: 10.1111/trf.14993.
    PubMed     Text format     Abstract available
    
    
    
21. LEE JH, Park J, Lee JW
    Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.
    Transfusion. 2018 Nov 1. doi: 10.1111/trf.14838.
    PubMed     Text format     Abstract available
    
    
    
22. CHOU ST
    "Rare" reagent red cells: rare no longer?
    Transfusion. 2018;58:2469-2471.
    PubMed     Text format    
    
    
    
23. KIKUCHI G, Kurita R, Ogasawara K, Isa K, et al
    Application of immortalized human erythroid progenitor cell line in serologic tests to detect red blood cell alloantibodies.
    Transfusion. 2018;58:2675-2682.
    PubMed     Text format     Abstract available
    
    
    October 2018
24. GRIFFITH LM, VanRaden M, Barrett AJ, Childs RW, et al
    Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
    Transfusion. 2018 Oct 26. doi: 10.1111/trf.14966.
    PubMed     Text format     Abstract available
    
    
    
25. VERDU-AMOROS J, Woessmann W, Maecker-Kolhoff B, Schulz A, et al
    Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
    Transfusion. 2018 Oct 6. doi: 10.1111/trf.14880.
    PubMed     Text format     Abstract available
    
    
    September 2018
26. IEMURA T, Itoh M, Mano C, Oba A, et al
    Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14885.
    PubMed     Text format     Abstract available
    
    
    
27. KLEINMAN S, Stassinopoulos A
    Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14930.
    PubMed     Text format     Abstract available
    
    
    
28. INIESTA P, Revilla N, Chen-Liang TH, Hurtado AM, et al
    An early increase of CD56(bright) natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14964.
    PubMed     Text format     Abstract available
    
    
    
29. ARLT N, Rothe R, Sielaff S, Juretzek T, et al
    Sterility release testing of peripheral blood stem cells for transplantation: impact of culture bottles and incubation temperature.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14910.
    PubMed     Text format     Abstract available
    
    
    
30. RUSSELL AL, Lefavor RC, Zubair AC
    Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14805.
    PubMed     Text format     Abstract available
    
    
    
31. ALVA LC, Bacher U, Seipel K, Mansouri Taleghani B, et al
    Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14895.
    PubMed     Text format     Abstract available
    
    
    
32. HESS J, Su L, Nizzi F, Beebe K, et al
    Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
    Transfusion. 2018 Sep 4. doi: 10.1111/trf.14907.
    PubMed     Text format     Abstract available
    
    
    
33. TAKANASHI M, Selogie E, Reems JA, Stroncek D, et al
    Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
    Transfusion. 2018;58:2184-2191.
    PubMed     Text format     Abstract available
    
    
    July 2018
34. SPOERL S, Wascher D, Nagel S, Peschel C, et al
    Evaluation of the new continuous mononuclear cell collection protocol versus an older version on two different apheresis machines.
    Transfusion. 2018;58:1772-1780.
    PubMed     Text format     Abstract available
    
    
    May 2018
35. AHN H, Tay J, Shea B, Hutton B, et al
    Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Transfusion. 2018 May 16. doi: 10.1111/trf.14656.
    PubMed     Text format     Abstract available
    
    
    
36. SIEGEL G, Fleck E, Elser S, Hermanutz-Klein U, et al
    Manufacture of endothelial colony-forming progenitor cells from steady-state peripheral blood leukapheresis using pooled human platelet lysate.
    Transfusion. 2018;58:1132-1142.
    PubMed     Text format     Abstract available
    
    
    April 2018
37. NIITTYVUOPIO R, Juvonen E, Heiskanen J, Lindstrom V, et al
    Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Transfusion. 2018 Apr 29. doi: 10.1111/trf.14649.
    PubMed     Text format     Abstract available
    
    
    
38. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    PubMed     Text format     Abstract available
    
    
    
39. CASTRO G, Merkel PA, Giclas HE, Gibula A, et al
    Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Transfusion. 2018 Apr 2. doi: 10.1111/trf.14589.
    PubMed     Text format     Abstract available
    
    
    March 2018
40. RUSSELL AL, Lefavor R, Durand N, Glover L, et al
    Modifiers of mesenchymal stem cell quantity and quality.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14597.
    PubMed     Text format     Abstract available
    
    
    
41. BOJANIC I, Mravak Stipetic M, Pulanic D, Desnica L, et al
    Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease.
    Transfusion. 2018 Mar 14. doi: 10.1111/trf.14594.
    PubMed     Text format     Abstract available
    
    
    
42. WANG T, Remberger M, Axdorph Nygell U, Sundin M, et al
    Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.
    Transfusion. 2018 Mar 13. doi: 10.1111/trf.14579.
    PubMed     Text format     Abstract available
    
    
    February 2018
43. MARCHESI F, Vacca M, Giannarelli D, Ipsevich F, et al
    Lenograstim 5 microg/kg is not superior to biosimilar filgrastim 10 microg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14533.
    PubMed     Text format     Abstract available
    
    
    
44. WOREL N, Lehner E, Fuhrer H, Kalhs P, et al
    Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14506.
    PubMed     Text format     Abstract available
    
    
    
45. REICH-SLOTKY R, Cushing MM, Hsu YS, Ancharski M, et al
    Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
    Transfusion. 2018;58:339-344.
    PubMed     Text format     Abstract available
    
    
    
46. PARK G, Shayani S, Stiller T, Wang S, et al
    Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings.
    Transfusion. 2018;58:323-329.
    PubMed     Text format     Abstract available
    
    
    December 2017
47. ZHU J, Huang H, Chen H, Zhang X, et al
    Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study.
    Transfusion. 2017 Dec 13. doi: 10.1111/trf.14426.
    PubMed     Text format     Abstract available
    
    
    
48. VILLA CH, Porturas T, Sell M, Wall M, et al
    Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers.
    Transfusion. 2017 Dec 11. doi: 10.1111/trf.14449.
    PubMed     Text format     Abstract available
    
    
    
49. PIERCE J, Benedetti E, Preslar A, Jacobson P, et al
    Comparative analyses of industrial-scale human platelet lysate preparations.
    Transfusion. 2017;57:2858-2869.
    PubMed     Text format     Abstract available
    
    
    November 2017
50. PIERELLI L, Bosi A, Olivieri A
    "Best practice" for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa' Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of app
    Transfusion. 2017 Nov 13. doi: 10.1111/trf.14400.
    PubMed     Text format     Abstract available
    
    
    
51. SOURI M, Nikougoftar Zarif M, Rasouli M, Golzadeh K, et al
    Comparison of human umbilical cord blood processing with or without hydroxyethyl starch.
    Transfusion. 2017;57:2758-2766.
    PubMed     Text format     Abstract available
    
    
    September 2017
52. FINGRUT W, Parmar S, Cuperfain A, Rikhraj K, et al
    The Stem Cell Club: a model for unrelated stem cell donor recruitment.
    Transfusion. 2017 Sep 24. doi: 10.1111/trf.14327.
    PubMed     Text format     Abstract available
    
    
    July 2017
53. ALBANO MS, Ciubotariu R, Dobrila L, Tarnawski M, et al
    Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.
    Transfusion. 2017 Jul 31. doi: 10.1111/trf.14257.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: